Understanding the importance of TIR17 for medical device manufacturers: TIR17 has evolved over the years to be a necessary resource for device manufacturers, says Wendy Wangsgard, Nelson Labs.
Understanding the Importance of TIR17 for Medical Device Manufacturers
Published In: Medical Plastics News
November 20, 2018
Wendy Wangsgard is a recognized authority and industry leader on Radiation Sterilization and Bioburden. She has over 17 years of experience working in research and laboratory functions in research, medical device and tissue industries. Wendy has worked with clients to consult on failure investigations, bioburden issues, establishing bioburden alert and action levels, product family grouping, radiation sterilization and tissue validations. She is a member of the Association for the Advancement of Medical Instrumentation (AAMI) involved in the working groups for Radiation Sterilization, Microbiological Methods, Assurance of Sterility, Sterilization Terminology and the Compatibility of Materials Subject to Sterilization. Currently she is assisting in developing the HealthCare Strand of programming for the 40th Anniversary International Meeting on Radiation Processing. She is also a member of the American Association of Tissue Banks (AATB) and a Registered Microbiologist with the National Registry of Certified Microbiologists (NRCM). She graduated from the University of Utah with a B.S. in Biochemistry and a Ph.D. in Pharmacology and Toxicology.